Parex Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 7.20 M
as on 23-10-2024
- Paid Up Capital ₹ 6.39 M
as on 23-10-2024
- Company Age 46 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.00 M
as on 23-10-2024
- Satisfied Charges ₹ 2.76 M
as on 23-10-2024
- Revenue -14.58%
(FY 2023)
- Profit -35.89%
(FY 2023)
- Ebitda -16.32%
(FY 2023)
- Net Worth -1.94%
(FY 2023)
- Total Assets -0.33%
(FY 2023)
About Parex Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.20 M and a paid-up capital of Rs 6.39 M.
The company currently has active open charges totaling ₹9.00 M. The company has closed loans amounting to ₹2.76 M, as per Ministry of Corporate Affairs (MCA) records.
Pervinder Singh and Jagdeep Singh serve as directors at the Company.
- CIN/LLPIN
U24231PB1978PTC003850
- Company No.
003850
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jul 1978
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- LocationPunjab, Punjab
- Telephone
- Email Address
- Website
- Social Media
What products or services does Parex Pharmaceuticals Private Limited offer?
Parex Pharmaceuticals Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Diabetic Herbal Medicine, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Respiratory System Drugs, Anti Asthma Drug, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Common Disease Medicines, Anaemia Medicine.
Who are the key members and board of directors at Parex Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagdeep Singh  | Managing Director | 19-Jul-1978 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pervinder Singh | Director | 15-Jun-2002 | Current |
Financial Performance of Parex Pharmaceuticals.
Parex Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.58% decrease. The company also saw a substantial fall in profitability, with a 35.89% decrease in profit. The company's net worth dipped by a decrease of 1.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Parex Pharmaceuticals?
In 2023, Parex Pharmaceuticals had a public holding of 29.39%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 20 Sep 2022 | ₹3.00 M | Open |
State Bank Of Patiala Creation Date: 16 Jan 2014 | ₹1.00 M | Open |
State Bank Of India Creation Date: 08 Oct 2009 | ₹5.00 M | Open |
How Many Employees Work at Parex Pharmaceuticals?
Parex Pharmaceuticals has a workforce of 7 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Parex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parex Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
